From the Department of Plastic and Reconstructive Surgery, Erasmus MC Cancer Institute, University Medical Centre Rotterdam; Department of Research, Netherlands Comprehensive Cancer Organisation; Department of Health Technology and Services Research, Technical Medical Centre, University of Twente; Department of Psychiatry, Section of Medical Psychology and Psychotherapy, Erasmus Medical Center; Department of Plastic, Reconstructive, and Hand Surgery, Hospital Medisch Spectrum Twente/Hospital Group Twente; and Department of Surgery, Hospital Group Twente.
Plast Reconstr Surg. 2020 Jul;146(1):1-13. doi: 10.1097/PRS.0000000000006887.
Differences in quality-of-life outcomes after different surgical breast cancer treatment options, including breast reconstruction, are relevant for counseling individual patients in clinical decision-making, and for (societal) evaluations such as cost-effectiveness analyses. However, current literature shows contradictory results, because of use of different patient-reported outcome measures and study designs with limited patient numbers. The authors set out to improve this evidence using patient-reported outcome measures in a large, cross-sectional study for different surgical breast cancer treatment options.
Quality of life was assessed through the EQ-5D-5L, European Organization for Research and Treatment of Cancer Quality of Life Questionnaires C30 and BR23, and the BREAST-Q. Patients with different treatments were compared after propensity-weighted adjustment of pretreatment differences. The EQ-5D was used to value the effect of surgical complications.
A total of 1871 breast cancer patients participated (breast-conserving surgery, n = 615; mastectomy, n = 507; autologous reconstruction, n = 330; and implant-based reconstruction, n = 419). Mastectomy patients reported the lowest EQ-5D score (mastectomy, 0.805, breast-conserving surgery, 0.844; autologous reconstruction, 0.849; and implant-based reconstruction, 0.850) and functioning scores of the C30 questionnaire. On the BREAST-Q, autologous reconstruction patients had higher mean Satisfaction with Outcome, Satisfaction with Breasts, and Sexual Well-being scores than implant-based reconstruction patients. Complications in autologous reconstruction patients resulted in a substantially lower quality of life than in implant-based reconstruction patients.
This study shows the added value of breast conservation and reconstruction compared with mastectomy; however, differences among breast-conserving surgery, implant-based reconstruction, and autologous breast reconstruction were subtle. Complications resulted in poorer health-related quality of life.
不同的手术乳腺癌治疗选择(包括乳房重建)后的生活质量结果存在差异,这对于在临床决策中为个体患者提供咨询以及进行(社会)评估(如成本效益分析)都很重要。然而,由于使用了不同的患者报告结局测量方法和研究设计,患者人数有限,目前的文献结果存在矛盾。作者旨在使用患者报告结局测量方法,在一项针对不同手术乳腺癌治疗选择的大型横断面研究中改进这一证据。
使用 EQ-5D-5L、欧洲癌症研究与治疗组织生活质量问卷 C30 和 BR23 以及 BREAST-Q 评估生活质量。通过对预处理差异进行倾向评分调整后,比较不同治疗方法的患者。使用 EQ-5D 来评估手术并发症的影响。
共有 1871 名乳腺癌患者参与(保乳手术,n=615;乳房切除术,n=507;自体重建,n=330;和植入物重建,n=419)。乳房切除术患者报告的 EQ-5D 评分最低(乳房切除术,0.805;保乳手术,0.844;自体重建,0.849;和植入物重建,0.850)和 C30 问卷的功能评分最低。在 BREAST-Q 上,自体重建患者的结局满意度、乳房满意度和性健康评分均高于植入物重建患者。自体重建患者的并发症导致生活质量显著低于植入物重建患者。
本研究表明与乳房切除术相比,乳房保留和重建具有附加价值;然而,保乳手术、植入物重建和自体乳房重建之间的差异很细微。并发症导致健康相关生活质量下降。